The University of Chicago Header Logo

Connection

Kerstin Stenson to Enzyme Inhibitors

Back to Details
This is a "connection" page, showing publications Kerstin Stenson has written about Enzyme Inhibitors.
Kerstin Stenson
Connection Strength
0.008
Enzyme Inhibitors
  1. Phase I study of eniluracil, a dihydropyrimidine dehydrogenase inactivator, and oral 5-fluorouracil with radiation therapy in patients with recurrent or advanced head and neck cancer. Clin Cancer Res. 1999 Feb; 5(2):291-8.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.